Journal ArticleMethods Mol Biol · 2022
Our group has employed methodologies for effective ex vivo generation of dendritic cell (DC) vaccines for patients with primary malignant brain tumors. In order to reliably produce the most potent, most representational vaccinated DC that will engender an ...
Full textLink to itemCite